Dr. Beauty-KY announced on May 11, 2026, that its subsidiary, Hong Kong Dr. Beauty International Limited, will make an additional investment of NT$36,000,000 in ONVO BIOTECH CO., LTD. The purpose of this transaction is for Dr. Beauty-KY to participate in the financing of ONVO BIOTECH as an existing shareholder. Following this investment, Dr. Beauty-KY's indirect shareholding in ONVO BIOTECH will be 4%. The investment represents 0.37% of Dr. Beauty-KY's total assets and 0.65% of its owner's equity. The funds for this investment will come from the company's own capital. The board of directors has authorized the chairman to handle all related administrative procedures.
FACT BOX
- Source: PR Times
- Category: News